{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:45Z","timestamp":1792839645395,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovacion","doi-asserted-by":"crossref","award":["MICINN; SAF2008-02461"],"award-info":[{"award-number":["MICINN; SAF2008-02461"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovacion","doi-asserted-by":"crossref","award":["BFU2008-02373"],"award-info":[{"award-number":["BFU2008-02373"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovacion","doi-asserted-by":"crossref","award":["FIS06\/0623"],"award-info":[{"award-number":["FIS06\/0623"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundacio La Marato de TV3","award":["MARATO-081210"],"award-info":[{"award-number":["MARATO-081210"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jhep.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T04:18:35Z","timestamp":1265343515000},"page":"529-539","source":"Crossref","is-referenced-by-count":98,"title":["Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension"],"prefix":"10.1016","volume":"52","author":[{"given":"Marc","family":"Mejias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Garcia-Pras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.01.004_bib1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/bega.2000.0144","article-title":"Splenomegaly, hypersplenism and coagulation abnormalities in liver disease","volume":"14","author":"McCormick","year":"2000","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2010.01.004_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.004_bib3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cgh.2008.05.004","article-title":"Spleen enlargement on follow-up evaluation: a noninvasive predictor of complications of portal hypertension in cirrhosis","volume":"6","author":"Berzigotti","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005792-194805000-00002","article-title":"The pathogenesis of splenomegaly in hypertension of the portal circulation: congestive splenomegaly","volume":"27","author":"Moschowitz","year":"1988","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2010.01.004_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1590-8658(02)80246-8","article-title":"Role of spleen enlargement in cirrhosis with portal hypertension","volume":"34","author":"Bolognesi","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2010.01.004_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tcb.2006.02.002","article-title":"Complexity of the mTOR signaling network","volume":"16","author":"Inoki","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.jhep.2010.01.004_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","article-title":"TOR, a central controller of cell growth","volume":"103","author":"Schmelzle","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2010.01.004_bib9","doi-asserted-by":"crossref","first-page":"26776","DOI":"10.1074\/jbc.274.38.26776","article-title":"P70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation","volume":"274","author":"Vi\u00f1als","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2010.01.004_bib10","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target or rapamycin","volume":"100","author":"Mayerhofer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2010.01.004_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1096\/fj.01-0658com","article-title":"Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling","volume":"16","author":"Humar","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2010.01.004_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2010.01.004_bib13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.104.079616","article-title":"Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms","volume":"313","author":"Biecker","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2010.01.004_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2006.07.030","article-title":"Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis","volume":"45","author":"Neef","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc1362","article-title":"The TOR pathway: a target for cancer therapy","volume":"4","author":"Bjornsti","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2010.01.004_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","article-title":"Targeting mammalian target of rapamycin (mTOR) for health and diseases","volume":"12","author":"Tsang","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jhep.2010.01.004_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.273.5272.239","article-title":"Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP","volume":"273","author":"Choi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jhep.2010.01.004_bib18","first-page":"8451","article-title":"Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells","volume":"63","author":"Edinger","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2010.01.004_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","article-title":"Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats","volume":"46","author":"Fernandez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.004_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00007691-199512000-00020","article-title":"Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations","volume":"17","author":"Yatscoff","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jhep.2010.01.004_bib21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.004_bib22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2003.12.012","article-title":"Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice","volume":"126","author":"Fernandez","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.01.004_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2005.02.022","article-title":"Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats","volume":"43","author":"Fernandez","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.004_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"Fernandez","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.01.004_bib25","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1083\/jcb.102.5.1738","article-title":"Stress fibres in the splenic sinus endothelium in situ: molecular structure, relationship to the extracellular matrix, and contractility","volume":"102","author":"Drenckhahn","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jhep.2010.01.004_bib26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2010.01.004_bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1440-1827.1995.tb03516.x","article-title":"Structural characteristics of splenic sinuses in idiopathic portal hypertension","volume":"45","author":"Maesawa","year":"1995","journal-title":"Pathol Int"},{"key":"10.1016\/j.jhep.2010.01.004_bib28","first-page":"697","article-title":"Ki-67 immunoexpression is a robust marker of proliferative cells in the rat","volume":"77","author":"Gerlach","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2010.01.004_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2010.01.004_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)81042-9","article-title":"Die and let live: eliminating dangerous lymphocytes","volume":"84","author":"Abbas","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2010.01.004_bib31","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1038\/10026","article-title":"How BAD phosphorylation is good for survival","volume":"1","author":"Downward","year":"1999","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jhep.2010.01.004_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.76.3.412","article-title":"Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells","volume":"76","author":"Marx","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.jhep.2010.01.004_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.107.07104","article-title":"Pharmacological and clinical aspects of heme oxygenase","volume":"60","author":"Abraham","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jhep.2010.01.004_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/369565a0","article-title":"Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo","volume":"369","author":"Lok","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2010.01.004_bib35","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Elthrombopag for thrombocytopenia in patients with cirrhosis associated hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.01.004_bib36","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0092-8674(00)81810-3","article-title":"Blood vessel formation: what is its molecular basis?","volume":"87","author":"Folkman","year":"1996","journal-title":"Cell"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T07:23:57Z","timestamp":1544685837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0168827810000127"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.01.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}